Schedule 13D ownership disclosure

SOLENO THERAPEUTICS INC

Security class unavailable · CUSIP: 834203200

Event date: 2022-03-29

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
18,368,373
Percent of class
15.3000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000905718-22-000559
Form type
SC 13D/A
Filer
Abingworth LLP
CIK
CIK 1397144
Filed
Apr 08, 2022
Reporting period
Mar 29, 2022
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub